Safety assessment of the Cistanche tubulosa health food product Memoregain®: Genotoxicity and 28-day repeated dose toxicity test

Po Lin Liao, Ching Hao Li, Ling Shan Tse, Jaw Jou Kang, Yu Wen Cheng

研究成果: 雜誌貢獻文章同行評審

13 引文 斯高帕斯(Scopus)

摘要

The pharmacological effects of Cistanches Herba, known as “Ginseng of the desert” have been extensively studied. In this study, we aimed to assess the genotoxic and oral toxic effects of the Cistanche tubulosa health food product Memoregain® using in vitro and in vivo tests. Ames tests using five strains of Salmonella typhimurium showed no signs of increased reverse mutation upon exposure to Memoregain® up to a concentration of 5 mg/plate. Exposure of Chinese hamster ovary (CHO-K1) cells to Memoregain® did not increase the frequency of chromosomal aberrations in vitro. Moreover, Memoregain® treatment did not affect the proportions of immature to total erythrocytes or the number of micronuclei in the immature erythrocytes of ICR mice. Additionally, after 28-day repeated oral dose toxicity tests (0, 0.15, 0.3, and 0.5g/kg body weight) in rats, no observable adverse effects were found. These toxicological assessments supported the safety of Memoregain® for human consumption.
原文英語
頁(從 - 到)581-588
頁數8
期刊Food and Chemical Toxicology
118
DOIs
出版狀態已發佈 - 8月 1 2018

Keywords

  • 28-day repeated oral dose toxicity
  • Cistanche tubulosa
  • Genotoxicity test
  • No-observed-adverse-effect-level

ASJC Scopus subject areas

  • 食品科學
  • 毒理學

指紋

深入研究「Safety assessment of the Cistanche tubulosa health food product Memoregain®: Genotoxicity and 28-day repeated dose toxicity test」主題。共同形成了獨特的指紋。

引用此